Pushpa Joshi

Dr. Pushpa Joshi

Senior Lecturer of Experimental Myology, Department of Neurology, Martin-Luther University Halle-Wittenberg, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Pushpa JoshiPushpa Joshi
Pushpa Joshi
SStephan Zierz
Stephan Zierz
Carnitine palmitoyltransferase (CPT) catalyzes the transfer of long- and medium-chain fatty acids from cytoplasm into mitochondria, where oxidation of fatty acids takes place. Deficiency of CPT enzyme is associated with rare diseases of fatty acid metabolism. CPT is present in two subforms: CPT I at the outer mitochondrial membrane and carnitine palmitoyltransferase II (CPT II) inside the mitochondria. Deficiency of CPT II results in the most common inherited disorder of long-chain fatty acid oxidation affecting skeletal muscle. There is a lethal neonatal form, a severe infantile hepato-cardio-muscular form, and a rather mild myopathic form characterized by exercise-induced myalgia, weakness, and myoglobinuria. Total CPT activity (CPT I + CPT II) in muscles of CPT II-deficient patients is generally normal. Nevertheless, in some patients, not detectable to reduced total activities are also reported. CPT II protein is also shown in normal concentration in patients with normal CPT enzymatic activity. However, residual CPT II shows abnormal inhibition sensitivity towards malonyl-CoA, Triton X-100 and fatty acid metabolites in patients. Genetic studies have identified a common p.Ser113Leu mutation in the muscle form along with around 100 different rare mutations. The biochemical consequences of these mutations have been controversial. Hypotheses include lack of enzymatically active protein, partial enzyme deficiency and abnormally regulated enzyme. The recombinant enzyme experiments that we recently conducted have shown that CPT II enzyme is extremely thermoliable and is abnormally inhibited by different emulsifiers and detergents such as malonyl-CoA, palmitoyl-CoA, palmitoylcarnitine, Tween 20 and Triton X-100. Here, we present a conceptual overview on CPT II deficiency based on our own findings and on results from other studies addressing clinical, biochemical, histological, immunohistological and genetic aspects, as well as recent advancements in diagnosis and therapeutic strategies in this disorder.

1 March 2014 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
Pushpa JoshiPushpa Joshi
Pushpa Joshi
MDMarcus Deschauer
Marcus Deschauer
SZStephan Zierz
Stephan Zierz

7 March 2024 in Geriatrics
Verified
Journal Article
Open access
PDF file
Pushpa JoshiPushpa Joshi
Pushpa Joshi
As the global population ages, pulmonary diseases among older people have emerged as a significant and growing public health concern. The increasing incidence of these conditions has led to higher rates of morbidity and mortality among older adults. This perspective study offers a thorough overview of the prevalent pulmonary diseases affecting the elderly demographic. It delves into the challenges encountered during the diagnosis and management of these conditions in older individuals, considering factors such as comorbidities, functional limitations, and medication complexities. Furthermore, innovative strategies and personalized interventions such as precision medicine, advanced therapies, telemedicine solutions, and patient-centered support systems aimed at enhancing the care provided to older individuals grappling with pulmonary disorders are thoroughly explored. By addressing the unique needs and complexities of this vulnerable population, healthcare systems can strive towards improving outcomes and enhancing the quality of life for elderly individuals affected by pulmonary diseases.

10 July 2008 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
Pushpa JoshiPushpa Joshi
Pushpa Joshi
DGD. Gläser
D. Gläser
SSS. Schmidt
S. Schmidt
MVM. Vorgerd
M. Vorgerd
MWM. Winterholler
M. Winterholler
MDM. Deschauer
M. Deschauer

1 November 2014 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
Pushpa JoshiPushpa Joshi
Pushpa Joshi
MVMirjam Vetterke
Mirjam Vetterke
AHAnja Hauburger
Anja Hauburger
PTPawel Tacik
Pawel Tacik
GSGisela Stoltenburg
Gisela Stoltenburg
FHFrank Hanisch
Frank Hanisch

1 January 2019 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
Pushpa JoshiPushpa Joshi
Pushpa Joshi
MDMarcus Deschauer
Marcus Deschauer
SZStephan Zierz
Stephan Zierz